Abstract: The invention relates to transdermal therapeutic systems (TTS) comprising a backing, a reservoir layer containing at least one pharmaceutical active ingredient, and an adhesive. Said transdermal therapeutic systems are characterized in that they are able to continuously adhere to the surface of the skin over a long period of time. During said long period of time, a) there is at least one time interval during which the TTS adhering to the surface of the skin is intensively exposed to water, and b) the active ingredient is transdermally released. The invention also relates to a method for the continuous transdermal release of at least one pharmaceutical active ingredient over a long period of time.

Abstract: Water-soluble, solid, film-shaped preparations comprising at least one film-forming polymer selected from the group consisting of the fully and partially hydrolyzed polyvinyl alcohols, and at least one water-insoluble, oily liquid which is incorporated into the film-forming polymer and amounts to at least 30 percent by weight, relative to the dry portion of the preparation. Methods for producing the preparations and the use thereof are also provided.

Abstract: Transdermal therapeutic system with which at least one pharmaceutical active substance that is non-volatile at room temperature can be administered at a daily dose of at most 30 mg, comprising a rear surface directed away from the skin and impermeable to the active substance, an adjoining polymer layer located away from the skin and based on polyisobutylene with a coating weight of at least 80 g/m2, an adhesive skin contact layer resting on the skin-remote polymer layer and based on acrylate copolymers with a coating weight of at most 50 g/m2, and a protective layer that is impermeable to the active substance and can be peeled off from the skin contact layer.

Abstract: An adhesive for medical patches or for transdermal therapeutic systems which contains a component or a combination of at least two components, such as (a) polyvinyl alcohols, (b) cellulose derivatives, (c) polyethers, (d) acid anhydrides and their acids and salts, as well as (e) non-pressure-sensitive adhesive polyacrylates. The adhesive has a tackiness which is activated and/or increased by contact with moisture or by absorption of moisture.

Abstract: Strip-shaped forms of administration for administering an active ingredient via the mucous membrane of the gums.

Abstract: The invention relates to a method for improving the permeability of the human skin in order to transdermally supply active substances, permeability being improved by means of a plaster that is transparent in at least some areas, contains active substance, and is flexible in at least some areas, and at least one external light source. According to said method, light that is emitted at least for a short period of time by an external light source and normally impinges at least some areas of the plaster is focused onto the stratum corneum of the skin with the aid of a plurality of individual focusing lenses which are integrated into the plaster so as to bring about changes in the stratum corneum, said changes improving the permeability of the skin. The inventive method for improving the permeability of the human skin allows for reproducible permeability for specific active substances.

Abstract: The invention relates to a web-form packaging material which comprises at least one layer, comprising a packaging material surface, of a sealable material, to a packaging unit with a transdermal therapeutic system and with a packaging material of this kind, and also to a process for producing a packaging unit. For this purpose, at least the abovementioned surface of the packaging material has a multiplicity of recesses and/or a multiplicity of non-recessed regions. The distance between two adjacent recesses and/or the distance between two adjacent non-recessed regions is less than five times the packaging material thickness. Moreover, the depth of the recesses is not less than 1.2 nanometers and not more than 95% of the packaging material thickness. With the present invention, the sticking of an adhesive on the inner face of the packaging material is effectively prevented.

Abstract: The invention relates to a protective or process film, produced of a thermoplastic material for use in the production of laminates of medical technology and to a laminate which comprises an adhesive-containing transdermal therapeutic system and a protective or process film adhering to the adhesive of the transdermal therapeutic system with a surface. The protective or process film comprises at least one surface that has a plurality of recesses and/or a plurality of non-recessed portions. The distance of two adjacent recesses and/or the distance of two adjacent non-recessed portions is less than five times the film thickness. The depth of the recesses is not less than 1.2 nanometer and not more than 95% of the film thickness. The film according to the invention effectively prevents the adhesive from sticking to the protective or process film.

Abstract: A pressure sensitive adhesive for medicinal application purposes, based on ethylene-vinyl acetate copolymers is characterized in that it contains as polymer component (A) an ethylene-vinyl acetate copolymer or a combination of at least two ethylene-vinyl acetate copolymers, and as component (B) an adhesive resin or a combination of adhesive resins at a portion of up to 55%-wt, relative to the sum of components (A) and (B) without active substances or other auxiliary substances.

Abstract: The invention relates to a transdermal therapeutic system for applying an active ingredient or several active ingredients to the skin. Elongate hollow bodies are incorporated into one of the layers of the TTS, said hollow bodies containing a filling medium or several filling mediums. The invention also relates to the production and use of said type of systems.

Abstract: The invention relates to transdermal therapeutic systems (TTS) comprising a backing, a reservoir layer containing at least one pharmaceutical active ingredient, and an adhesive. Said transdermal therapeutic systems are characterised in that they are able to continuously adhere to the surface of the skin over a long period of time. During said long period of time, a) there is at least one time interval during which the TTS adhering to the surface of the skin is intensively exposed to water, and b) the active ingredient is transdermally released. The invention also relates to a method for the continuous transdermal release of at least one pharmaceutical active ingredient over a long period of time.

Abstract: A multilayer preparation in the form of films of hydrophilic polymers for rapid release of substances present in the film layers into liquid surroundings is characterized in that adjacent layers differ from one another in that in each case one layer is soluble in a nonaqueous solvent in which the respective adjacent layer is insoluble or only slightly soluble.

Abstract: The present invention relates to a quickly decomposing oral drug preparation, for the application of active ingredient combinations for smoking withdrawal, which contains nicotine, a nicotine salt, a nicotine derivative, or a substance that reacts to nicotine, in combination with another active ingredient, and the use of such a drug preparation for the treatment of smoking withdrawal, and the use of nicotine, and/or nicotine salts or derivatives, for the production of medications for the treatment of smoking withdrawal. The active ingredient that is to be administered, in combination, for this purpose is a centrally active ingredient, preferably an antidepressant for the fighting of psychic dependency in terms of a smoking withdrawal therapy. The administration of the active ingredient combination to the patient should be handled in a simple and reliable way and should exclude side effects to a large extent.

Abstract: The invention relates to a method of producing adhesive die-cut articles with internal cut-outs 3 from an endless web 1, the web having a carrier layer 4, at least one adhesive layer 5 and, if appropriate, a matrix layer 6, and to a die-cut article produced by the method. In order to produce a die-cut article with an internal cut-out 3 whilst avoiding the use of a hollow punch, the contour 17 of the internal cut-out 3 and the external contour 10 of the respective die-cut article are die-cut out of the adhesive layer 5 and, if appropriate, the matrix layer 6 one after another, the external contour 10 not having any common point with the die-cutting line of the internal cut-out 3, the carrier layer 4 with the die-cutting residues from the internal cut-out 3 being pulled off over a pull-off edge, and the remaining web being transferred to a protective film 8.

Abstract: Administration forms for application to the skin or mucosa, comprising a carrier matrix and at least one active substance, are characterized in that the carrier matrix has a plurality of particles having open pores or containing capillary spaces, said particles serving as active substance reservoir and containing at least one active substance.

Abstract: The invention relates to laminate segments equipped or coated with an adhesive matrix, particularly transdermal therapeutic systems having formulations strongly tending to leak adhesive. The inventive laminate segments include a matrix, with or without a back layer, a protective layer on the adhesive side of the matrix, provided with a cut as a peel-off aid, and a cover film partially coated with adhesive, applied to the protective film, which overlaps the cut in the protective film using the adhesive-free part thereof The cover film prevents a leakage of the adhesive through the cut, and therefore a gluing together of the laminate segments to the packaging material thereof, without having an adverse effect on the function of the cut as a peel-off aid. Such laminate segments can be produced without the use of any intermediate carriers.

Abstract: A one-way injector having a housing in which at least one mechanical spring energy store, at least one piston/cylinder unit, which can be at least temporarily filled with an active substance, at least one piston-actuating plunger and at least one tripping unit are arranged. To this end, the spring energy store comprises a preloaded spring element. The spring element is held in the preloaded position by a tension means surrounding at least a region of the spring. The tripping unit comprises a cutting tool which, in order to release the energy of the spring energy store, severs or weakens the tension means at least one point, the weakening immediately tearing the tension means. With the present invention, a one-way injector is developed which, with a small overall size, has only a few components and ensures reliable mounting and functioning with simple manipulation.

Abstract: The invention relates to a method and a device for producing small, thin sheets from an active-ingredient film (2), in which the latter is produced by casting the film material onto a substrate material or by coating a substrate material, storing it with or without substrate material on a reel, pulling it off the reel and cutting it. It achieves the object of designing a method of this type in such a way that with this method small sheets can be produced as exactly as possible in predetermined sizes. To do this, the active-ingredient film (2) is pulled off automatically, is separated from a substrate material which, if present, and in tensioned form, is fed to a cutting station and is cut, in the feed direction, into long, narrow strips (7) of predeterminable width, and the long strips (7) are brought together in the feed direction and together are fed by a further feed device (10) to a transverse cutter (11), which cuts through the combined long strips (7) at predetermined intervals.

Abstract: Gastroretentive systems which have at least one release device for at least one active pharmaceutical ingredient and at least one swelling body that is connected to the release device.

Abstract: The invention relates to a transdermal therapeutic system for administering the active substance buprenorphine. Said system comprises at least one carboxylic acid that determines the solubility of buprenorphine in the matrix layer and that can likewise be absorbed. The transdermal therapeutic system according to the invention is used in the treatment of pain and is characterized by a considerably increased utilization of the active substance.